APRIL 27-29, 2017: International Integrative Oncology Conference – San Diego, CA

bacf-logo-awf-2012Come visit us at the International Integrative Oncology Conference, booth #6, to learn more about the important work of the Beljanski Foundation in searching for natural cures for cancer and other chronic diseases including the latest information regarding the scientific research underway on the effects of Dr. Mirko Beljanski’s plant extracts on cancer stem cells.

Don’t miss the presentation “Immune Support for Chemotherapy Patients” by Dr. John Hall, Senior Scientific Advisor of the Beljanski Foundation, on Friday, April 28th at 11:00 am.

Date:
April 27-29, 2017

Location:
Town and Country Resort and Convention Center
500 Hotel Circle North
San Diego, CA 92108

Learn More:
Best Answer For Cancer 2017 Conference

CAM

MARCH 2-4, 2017: Complementary & Alternative Cancer Therapies Conference – West Palm Beach, FL

annie apple seedDo not miss the opportunity to meet us at the 11th Annual Complementary & Alternative Cancer Therapies Conference in West Palm Beach.  Stop by our booth to learn more about the work of the Beljanski Foundation, and do not miss the presentation “Plant Extracts for Ovarian and Pancreatic Cancers and Cancer Stem Cells” by the Vice President of the Beljanski Foundation, Sylvie Beljanski on Friday, March 3rd, at 8:55 AM.

Date:
March 2-4, 2017

Location:Embassy Suites Hotel
1601 Belvedere Rd
West Palm Beach, FL 33406

Learn More:
11th Annual Complementary & Alternative Cancer Therapies Conference

Interview in the “Late Night Health” with Mark Alyn

markalyn_latenight_banner-1On August 29th, Sylvie Beljanski joined Late Night Health for a lively discussion on plant-based foods and Environmental medicine with Mark Alyn.

Late Night Health is a radio show dedicated to provide people with healthcare information covering a wide range of topics such as traditional, complementary, and alternative health issues that people can relate to.

Sylvie Beljanski introduced The Beljanski Foundation and discussed about the legacy of Mirko Beljanski. His early findings at the Pasteur Institute in France focused on the healing power of botanical extracts. Hence, the Beljanski Foundation, in partnership with prestigious American institutions, such as the Columbia University Medical Center and the University of Kansas Medical Center, bases their research on natural compounds with anti-cancer properties (Pao pereira and Rauwolfia vomitoria). The recent research in Environmental Medicine have shown promising results regarding patients diagnosed with cancer.

The promising results represent a significant breakthrough for the Environmental Medicine.

You can listen to the interview (two parts): Part 1   Part 2

Interview in “Hutch in the Morning” on WBTM

Sylvie Beljanski©The Beljanski Foundation, Inc.Sylvie Beljanski was interviewed by Dave “Hutch” Hutcheson on WBTM, in Hutch in the morning to talk about The Beljanski Foundation. Sylvie Beljanski introduced the Foundation and the studies they are conducting based on the research of Mirko Beljanski, considered as the father of Environmental Medicine. The Beljanski Foundation carries on the legacy of Mirko Beljanski by continuing the research against cancer.

You can listen to the interview here.

Interview in “Steve Fast’s Show” on WJBC

1400_wjbcamOn August 28th, Sylvie Beljanski, Vice-President of The Beljanski Foundation, was Steve Fast’s guest on WJBC. Sylvie Beljanski presented Mirko Beljanski’s research on natural compounds with anti-cancer properties such as Pao pereira or Rauwolfia vomitoria extract. She also presented the published research conducted on those compounds by prestigious American institutions, such as Columbia University Medical Center and the Cancer Treatment Centers of America and funded by The Beljanski Foundation.

The efficacy and lack of toxicity of the Pao pereira extract (as prepared by Dr. Beljanski) on different types of cancer cells and on synergy with chemotherapy has been confirmed by the recent studies.

You can listen to the interview here.

New article in the Townsend Letter: A Natural Approach to Cancer

The Natural Approach to Cancer

READ THE FULL ARTICLE

beljanskicoverweb1-copyThe Magazine Townsend Letter has published an article written by Sylvie Beljanski, the Vice-President of the Beljanski Foundation and daughter of Mirko Beljanski, Issue of August – September 2016. In the article titled “The Natural Approach to Cancer” Sylvie Beljanski explains that her father’s research has proved the correlation between the environment and its effects on the DNA. The environment, especially the one we are living in, with all the pollution and toxins for instance, constitutes one of the major causes of cancer. Mirko Beljanski is now considered as the father of Environmental Medicine for all the knowledge and progress his research brought to the war on cancer.

His dedication to find a cure to cancer of any kind with natural resources led him to discover natural extracts such as the Pao pereira, the Rauwolfia vomitoria, or the golden leaf of Ginkgo which help to re-organize a destabilized DNA.

Carrying on the legacy of Mirko Beljanski, and over the last 17 years The Beljanski Foundation has developed a research program with several high profile institutions to rigorously assess the anti-cancer potential of identified natural compounds.

All of those publications were published on peer reviewed Medical Journal and are available on Pubmed.gov (the US National Library of Medicine National Institutes of Health).

Prostate cancer

Columbia UniversityPre-cancerous and cancerous cells at Columbia University Medical Center

At Columbia University’s Department of Holistic Urology, preclinical and clinical studies were conducted with two plant extracts, Pao pereira and Rauwolfia vomitoria on prostate cancer cells and on men with prostate issues.

Advanced Cancer cells resistant to hormonal treatment at Nanjing University

Nanjing_UniversityThe research team at Nanjing University used innovative techniques to demonstrate that the Pao pereira extract is effective even against prostate cancer cells that no longer responded to androgen deprivation therapy.

Pancreatic Cancer at Kansas University Medical Center

Kansas university

Research was recently completed at Kansas University Medical Center where the effects of Pao pereira and Rauwolfia vomitoria were analyzed on pancreatic cancer cells. Two new scientific articles were published confirming the excellent results of these studies and the synergy with conventional chemotherapies. Over the course of the study, the Pao pereira was seen to suppress tumor growth significantly, by up to 72% and Gemcitabine at the dose used did not provide any reduction in tumor weight, when Rauwolfia vomitoria alone decreased tumor weight by 53% at the daily dose of 20 mg/kg, and 46% at the daily dose of 50 mg/kg, compared with saline-treated control. By combining Rauwolfia vomitoria with Gemcitabine, the decrease in tumor weight was 56% at both Rauwolfia vomitoria doses.

Ovarian Cancer at Kansas University Medical Center

The scientific team found that Rauwolfia vomitoria was effective against ovarian cancer cells both alone and in combination with carboplatin. The combination decreased tumor size in animal experiments by 87 to 90% and a second study concludes that “In vivo, Pao pereira alone suppressed tumor growth by 79% and decreased volume of ascites by 55%. When Pao pereira was combined with carboplatin, tumor inhibition reached 97% and ascites was completely eradicated.

Clinical Trial on Thrombocytopenia at Cancer Treatment Center of America

Small RNA fragments that specifically trigger DNA synthesis in healthy bone marrow stem cells, were used in another clinical trial for platelet support. The data reveals that E. coli RNA fragments stimulate platelet proliferation in chemotherapy patients. The study also proved that the source from which the RNA fragments are prepared is critical. The study concluded that Patients receiving E. coli RNA fragments demonstrated a more rapid recovery in platelet count and higher nadir platelet count. None of the patients receiving the E. coli RNA fragments required a chemotherapy dose reduction due to thrombocytopenia.

For more details, you can read the full article click here: The Natural Approach to Cancer.